Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 854530, 9 pages
http://dx.doi.org/10.1155/2015/854530
Review Article

Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma

1Epidemiology Unit, National Cancer Institute of Naples “G. Pascale Foundation”, IRCCS, 80131 Naples, Italy
2Department of Onco-Hematology, IRCCS, Cancer Referral Center of Basilicata, 85028 Rionero in Vulture, Italy
3Department of Medicine and Surgery, University of Salerno, 84081 Fisciano, Italy
4Animal Facility, National Cancer Institute of Naples “G. Pascale Foundation”, IRCCS, 80131 Naples, Italy
5Department of Pharmacy, University of Salerno, 84084 Fisciano, Salerno, Italy
6Department of Surgery, National Cancer Institute of Naples “G. Pascale Foundation”, IRCCS, 80131 Naples, Italy
7Department of Experimental Medicine, II University of Naples, 81055 Naples, Italy
8National Cancer Institute “G. Pascale Foundation”, IRCCS, 80131 Naples, Italy

Received 12 May 2015; Revised 29 June 2015; Accepted 1 July 2015

Academic Editor: Haifei Shi

Copyright © 2015 Maurizio Montella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Montella, A. Crispo, and A. Giudice, “HCC, diet and metabolic factors: diet and HCC,” Hepatitis Monthly, vol. 11, no. 3, pp. 159–162, 2011. View at Google Scholar · View at Scopus
  2. J. M. Llovet, A. Burroughs, and J. Bruix, “Hepatocellular carcinoma,” The Lancet, vol. 362, no. 9399, pp. 1907–1917, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Yu, J.-M. Yuan, S. Govindarajan, and R. K. Ross, “Epidemiology of hepatocellular carcinoma,” Canadian Journal of Gastroenterology, vol. 14, no. 8, pp. 703–709, 2000. View at Google Scholar · View at Scopus
  4. L. Gramantieri, F. Fornari, E. Callegari et al., “MicroRNA involvement in hepatocellular carcinoma,” Journal of Cellular and Molecular Medicine, vol. 12, no. 6A, pp. 2189–2204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. B. El-Serag and K. L. Rudolph, “Hepatocellular carcinoma: epidemiology and molecular carcinogenesis,” Gastroenterology, vol. 132, no. 7, pp. 2557–2576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W.-L. Ma, H.-C. Lai, S. Yeh, X. Cai, and C. Chang, “Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis,” Endocrine-Related Cancer, vol. 21, no. 3, pp. R165–R182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Parkin, “Global cancer statistics in the year 2000,” The Lancet Oncology, vol. 2, no. 9, pp. 533–543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-J. Jin, Y.-H. Chung, J. A. Kim et al., “Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma,” Digestive Diseases and Sciences, vol. 57, no. 11, pp. 2917–2923, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-M. Chu, C.-C. Lin, Y.-C. Chen, W.-J. Jeng, S.-M. Lin, and Y.-F. Liaw, “Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection,” British Journal of Cancer, vol. 107, no. 12, pp. 2010–2015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-F. Liaw and C.-M. Chu, “Hepatitis B virus infection,” The Lancet, vol. 373, no. 9663, pp. 582–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Murakami, “Hepatitis B virus X protein: a multifunctional viral regulator,” Journal of Gastroenterology, vol. 36, no. 10, pp. 651–660, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-H. Cheong, M.-K. Yi, Y. Lin, and S. Murakami, “Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation,” The EMBO Journal, vol. 14, no. 1, pp. 143–150, 1995. View at Google Scholar · View at Scopus
  13. X. W. Wang, K. Forrester, H. Yeh, M. A. Feitelson, J.-R. Gu, and C. C. Harris, “Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 6, pp. 2230–2234, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-H. Lee, S. J. Elledge, and J. S. Butel, “Hepatitis B virus X protein interacts with a probable cellular DNA repair protein,” Journal of Virology, vol. 69, no. 2, pp. 1107–1114, 1995. View at Google Scholar · View at Scopus
  15. Y.-H. Choi, H.-I. Kim, J. K. Seong et al., “Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor γ through protein-protein interaction,” FEBS Letters, vol. 557, no. 1–3, pp. 73–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Xue, J. Wong, G. T. Moreno, M. K. Young, J. Côté, and W. Wang, “NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities,” Molecular Cell, vol. 2, no. 6, pp. 851–861, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Jiang, L. Deng, L. Zhao et al., “miR-22 promotes HBV-related hepatocellular carcinoma development in males,” Clinical Cancer Research, vol. 17, no. 17, pp. 5593–5603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Hirankarn, I. Kimkong, P. Kummee, P. Tangkijvanich, and Y. Poovorawan, “Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection,” World Journal of Gastroenterology, vol. 12, no. 5, pp. 776–779, 2006. View at Google Scholar · View at Scopus
  19. V. W.-S. Wong, J. Yu, A. S.-L. Cheng et al., “High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B,” International Journal of Cancer, vol. 124, no. 12, pp. 2766–2770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P.-J. Chen, S.-H. Yeh, W.-H. Liu et al., “Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis,” Hepatology, vol. 56, no. 2, pp. 632–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Ladeiro, G. Couchy, C. Balabaud et al., “MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations,” Hepatology, vol. 47, no. 6, pp. 1955–1963, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, J. Cheng, C. Xu et al., “Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma,” Liver International, vol. 32, no. 3, pp. 420–428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Tian, W. Yang, J. Song, Y. Wu, and B. W. Ni, “Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis,” Molecular and Cellular Biology, vol. 33, no. 15, pp. 2810–2816, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Baig, “Gender disparity in infections of hepatitis B virus,” Journal of the College of Physicians and Surgeons—Pakistan, vol. 19, no. 9, pp. 598–600, 2009. View at Google Scholar · View at Scopus
  25. Z.-Z. Zhu, D. Wang, W.-M. Cong et al., “Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 1, pp. 225–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ruggieri, C. Barbati, and W. Malorni, “Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity,” International Journal of Cancer, vol. 127, no. 3, pp. 499–504, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Humphries, “Sex differences: luck of the chromosomes,” Nature, vol. 516, no. 729, pp. S10–S11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. H. B. El-Serag, “Epidemiology of viral hepatitis and hepatocellular carcinoma,” Gastroenterology, vol. 142, no. 6, pp. 1264–1273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-T. Huang, C.-L. Jen, H.-I. Yang et al., “Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C,” Journal of Clinical Oncology, vol. 29, no. 27, pp. 3643–3650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Farinati, N. De Maria, C. Marafin, S. Fagiuoli, G. D. Libera, and R. Naccarato, “Hepatocellular carcinoma in alcoholic cirrhosis is sex hormone imbalance a pathogenetic factor,” European Journal of Gastroenterology & Hepatology, vol. 7, no. 2, pp. 145–150, 1995. View at Google Scholar · View at Scopus
  31. M.-W. Yu, H.-C. Chang, S.-C. Chang et al., “Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk,” Hepatology, vol. 38, no. 6, pp. 1393–1400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M.-W. Yu and C.-J. Chen, “Elevated serum testosterone levels and risk of hepatocellular carcinoma,” Cancer Research, vol. 53, no. 4, pp. 790–794, 1993. View at Google Scholar · View at Scopus
  33. F.-H. Su, J.-D. Chen, S.-H. Cheng, C.-H. Lin, Y.-H. Liu, and F.-Y. Chu, “Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program,” Journal of Medical Virology, vol. 79, no. 2, pp. 138–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. T. Meadows, J. L. Naiman, and M. Valdes-Dapena, “Hepatoma associated with androgen therapy for aplastic anemia,” The Journal of Pediatrics, vol. 84, no. 1, pp. 109–110, 1974. View at Publisher · View at Google Scholar · View at Scopus
  35. J. J. Mulvihill, R. L. Ridolfi, F. R. Schultz, M. S. Borzy, and P. B. T. Haughton, “Hepatic adenoma in Fanconi anemia treated with oxymetholone,” The Journal of Pediatrics, vol. 87, no. 1, pp. 122–124, 1975. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Farza, A. M. Salmon, M. Hadchouel et al., “Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 5, pp. 1187–1191, 1987. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. DeLoia, R. D. Burk, and J. D. Gearhart, “Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice,” Journal of Virology, vol. 63, no. 9, pp. 4069–4073, 1989. View at Google Scholar · View at Scopus
  38. S. Breidbart, R. D. Burk, and P. Saenger, “Hormonal regulation of hepatitis B virus gene expression: influence of androgen receptor,” Pediatric Research, vol. 34, no. 3, pp. 300–302, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. S.-H. Yeh and P.-J. Chen, “Gender disparity of hepatocellular carcinoma: the roles of sex hormones,” Oncology, vol. 78, supplement 1, pp. 172–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Beato and J. Klug, “Steroid hormone receptors: an update,” Human Reproduction Update, vol. 6, no. 3, pp. 225–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Yamashita, “Localization and functions of steroid hormone receptors,” Histology and Histopathology, vol. 13, no. 1, pp. 255–270, 1998. View at Google Scholar · View at Scopus
  42. J. Cui, Y. Shen, and R. Li, “Estrogen synthesis and signaling pathways during aging: from periphery to brain,” Trends in Molecular Medicine, vol. 19, no. 3, pp. 197–209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. C. S. Chang, J. Kokontis, and S. Liao, “Molecular cloning of human and rat complementary DNA encoding androgen receptors,” Science, vol. 240, no. 4850, pp. 324–326, 1988. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Claessens, G. Verrijdt, E. Schoenmakers et al., “Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation,” Journal of Steroid Biochemistry and Molecular Biology, vol. 76, no. 1–5, pp. 23–30, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Yeh, H.-C. Chang, H. Miyamoto et al., “Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators,” The Keio Journal of Medicine, vol. 48, no. 2, pp. 87–92, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. E. G. Bluemn and P. S. Nelson, “The androgen/androgen receptor axis in prostate cancer,” Current Opinion in Oncology, vol. 24, no. 3, pp. 251–257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Nakatani, G. Roy, N. Fujimoto, T. Asahara, and A. Ito, “Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin,” Japanese Journal of Cancer Research, vol. 92, no. 3, pp. 249–256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. W.-L. Ma, C.-L. Hsu, M.-H. Wu et al., “Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma,” Gastroenterology, vol. 135, no. 3, pp. 947.e5–955.e5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Rinaldi, A. Lesmana, and L. A. Lesmana , “The role of liver biopsy in the non-invasive methods era and liver stiffness measurement using transient elastography,” in Liver Biopsy, H. Takahashi, Ed., chapter 1, InTech, Rijeka, Croatia, 2011. View at Publisher · View at Google Scholar
  50. D. L. Ahlbory-Dieker, B. D. Stride, G. Leder et al., “DNA binding by estrogen receptor-α is essential for the transcriptional response to estrogen in the liver and the uterus,” Molecular Endocrinology, vol. 23, no. 10, pp. 1544–1555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. D. J. Waxman and M. G. Holloway, “Sex differences in the expression of hepatic drug metabolizing enzymes,” Molecular Pharmacology, vol. 76, no. 2, pp. 215–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Kalra, J. Mayes, S. Assefa, A. K. Kaul, and R. Kaul, “Role of sex steroid receptors in pathobiology of hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 14, no. 39, pp. 5945–5961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. M.-H. Wu, W.-L. Ma, C.-L. Hsu et al., “Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription,” Science Translational Medicine, vol. 2, no. 32, pp. 32–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S.-H. Wang, S.-H. Yeh, W.-H. Lin, H.-Y. Wang, D.-S. Chen, and P.-J. Chen, “Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B,” Hepatology, vol. 50, no. 5, pp. 1392–1402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. W.-J. Yang, C.-J. Chang, S.-H. Yeh et al., “Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3β kinase pathways,” Hepatology, vol. 49, no. 5, pp. 1515–1524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. J. Bouchard, L. Wang, and R. J. Schneider, “Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication,” Journal of Virology, vol. 80, no. 9, pp. 4406–4414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. Q. Ding, W. Xia, J.-C. Liu et al., “Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin,” Molecular Cell, vol. 19, no. 2, pp. 159–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Feng, A. S. L. Cheng, D. P. Tsang et al., “Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis,” The Journal of Clinical Investigation, vol. 121, no. 8, pp. 3159–3175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Tan, U. Apte, A. Micsenyi et al., “Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver,” Gastroenterology, vol. 129, no. 1, pp. 285–302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. W. S. Moon, H. S. Park, K. H. Yu et al., “Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis,” Human Pathology, vol. 37, no. 10, pp. 1324–1332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. S.-I. Ueda, Y. Basaki, M. Yoshie et al., “PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib,” Cancer Research, vol. 66, no. 10, pp. 5346–5353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Almog, A. Klein, R. Adler, O. Laub, and R. Tur-Kaspa, “Estrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells,” Antiviral Research, vol. 19, no. 4, pp. 285–293, 1992. View at Publisher · View at Google Scholar · View at Scopus
  63. N. D. Maria, M. Manno, and E. Villa, “Sex hormones and liver cancer,” Molecular and Cellular Endocrinology, vol. 193, no. 1-2, pp. 59–63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. S.-H. Wang, S.-H. Yeh, W.-H. Lin et al., “Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α,” Gastroenterology, vol. 142, no. 4, pp. 989.e4–998.e4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. B. S. Katzenellenbogen and J. A. Katzenellenbogen, “Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer,” Breast Cancer Research, vol. 2, no. 5, pp. 335–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Tong, “Hepatitis B virus, a sex hormone-responsive virus,” Gastroenterology, vol. 142, no. 4, pp. 696–699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Han, L. Ding, B. Yuan et al., “Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells,” Nucleic Acids Research, vol. 34, no. 10, pp. 3095–3106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Petri, M. Lindow, and S. Kauppinen, “MicroRNA silencing in primates: towards development of novel therapeutics,” Cancer Research, vol. 69, no. 2, pp. 393–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Murakami, T. Yasuda, K. Saigo et al., “Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues,” Oncogene, vol. 25, no. 17, pp. 2537–2545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. J. L. Mott, “MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia,” Hepatology, vol. 50, no. 2, pp. 630–637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Visone, F. Petrocca, and C. M. Croce, “Micro-RNAs in gastrointestinal and liver disease,” Gastroenterology, vol. 135, no. 6, pp. 1866–1869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Gao, C. C.-L. Wong, E. K.-K. Tung, J. M.-F. Lee, C.-M. Wong, and I. O.-L. Ng, “Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis,” Journal of Hepatology, vol. 54, no. 6, pp. 1177–1184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. C.-P. Lin, Y. J. Choi, G. G. Hicks, and L. He, “The emerging functions of the p53-miRNA network in stem cell biology,” Cell Cycle, vol. 11, no. 11, pp. 2063–2072, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Xu, T. Papagiannakopoulos, G. Pan, J. A. Thomson, and K. S. Kosik, “MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells,” Cell, vol. 137, no. 4, pp. 647–658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Xuan, K. Han, M. Guo et al., “Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors,” PLoS ONE, vol. 8, no. 8, Article ID e70204, 2013. View at Publisher · View at Google Scholar
  77. Y. Ma, W. Bao-Han, X. Lv et al., “MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation,” PLoS ONE, vol. 8, no. 8, Article ID e72383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. C.-M. Chiu, S.-H. Yeh, P.-J. Chen et al., “Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 8, pp. 2571–2578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. W. E. Naugler, T. Sakurai, S. Kim et al., “Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production,” Science, vol. 317, no. 5834, pp. 121–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Nakagawa and S. Maeda, “Inflammation- and stress-related signaling pathways in hepatocarcinogenesis,” World Journal of Gastroenterology, vol. 18, no. 31, pp. 4071–4081, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. D. P. Pandey and D. Picard, “miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA,” Molecular and Cellular Biology, vol. 29, no. 13, pp. 3783–3790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. W.-H. Liu, S.-H. Yeh, C.-C. Lu et al., “MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells,” Gastroenterology, vol. 136, no. 2, pp. 683–693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. C.-L. Li, K.-H. Yeh, W.-H. Liu et al., “Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma,” International Journal of Cancer, vol. 136, no. 4, pp. 761–770, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. C.-S. Wu, C.-J. Yen, R.-H. Chou et al., “Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression,” International Journal of Cancer, vol. 134, no. 7, pp. 1638–1647, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. H. B. El-Serag, “Epidemiology of hepatocellular carcinoma,” Clinics in Liver Disease, vol. 5, no. 1, pp. 87–107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Schaedler, J. Krause, K. Himmelsbach et al., “Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2,” The Journal of Biological Chemistry, vol. 285, no. 52, pp. 41074–41086, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Dayoub, A. Vogel, J. Schuett et al., “Nrf2 activates augmenter of liver regeneration (ALR) via antioxidant response element and links oxidative stress to liver regeneration,” Molecular Medicine, vol. 19, no. 28, pp. 237–244, 2013. View at Google Scholar
  88. S.-L. Yang, C. Yu, J.-X. Jiang, L.-P. Liu, X. Fang, and C. Wu, “Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinoma,” Oncology Letters, vol. 8, no. 6, pp. 2715–2720, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Fu and C. C. Lee, “The circadian clock: pacemaker and tumour suppressor,” Nature Reviews Cancer, vol. 3, no. 5, pp. 350–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. J. M. Llovet, “Updated treatment approach to hepatocellular carcinoma,” Journal of Gastroenterology, vol. 40, no. 3, pp. 225–235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Mandlekar and A.-N. T. Kong, “Mechanisms of tamoxifen-induced apoptosis,” Apoptosis, vol. 6, no. 6, pp. 469–477, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Guo, T. Wang, H. Shen et al., “Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2,” Biomedicine and Pharmacotherapy, vol. 64, no. 4, pp. 249–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. P. K. H. Chow, B.-C. Tai, C.-K. Tan et al., “High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized controlled trial,” Hepatology, vol. 36, no. 5, pp. 1221–1226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. E. Villa, A. Colantoni, A. Grottola et al., “Variant estrogen receptors and their role in liver disease,” Molecular and Cellular Endocrinology, vol. 193, no. 1-2, pp. 65–69, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Chao, W.-K. Chan, Y.-S. Huang et al., “Phase II study of flutamide in the treatment of hepatocellular carcinoma,” Cancer, vol. 77, no. 4, pp. 635–639, 1996. View at Publisher · View at Google Scholar · View at Scopus